Herpes simplex virus type-1 (HSV-1) is one of many pathogens that use the cell surface glycosaminoglycan heparan sulfate as a receptor. Heparan sulfate is highly expressed on the surface and extracellular matrix of virtually all cell types making it an ideal receptor. Heparan sulfate interacts with HSV-1 envelope glycoproteins gB and gC during the initial attachment step during HSV-1 entry. In addition, a modified form of heparan sulfate, known as 3-O-sulfated heparan sulfate, interacts with HSV-1 gD to induce fusion between the viral envelope and host cell membrane. The 3-O-sulfation of heparan sulfate is a rare modification which occurs during the biosynthesis of heparan sulfate that is carried out by a family of enzymes known as 3-O-sulfotransferases. Due to its involvement in multiple steps of the infection process, heparan sulfate has been a prime target for the development of agents to inhibit HSV entry. Understanding how heparan sulfate functions during HSV-1 infection may not only be critical for inhibiting infection by this virus, but it may also be crucial in the fight against many other pathogens as well. (17, 45, 63) .
of HS begins with the assembly of the tetrasaccharide linker region (GlcA-Gal-Gal-Xyl) on serine residues of the protein core (17, 45, 63) . After the initial addition of an N-acetylated glucosamine (GlcNAc) residue to begin the HS chain, polymerization occurs by the addition of alternating GlcA and GlcNAc residues. As polymerization occurs, HS undergoes a series of modifications. The enzymes involved include glycosyltransferases, an epimerase, and sulfotransferases. First, N-deacetylation and N-sulfation of (66) .
HS FUNCTIONS IN HSV-1 INFECTION
The abundant expression of HS on the surface of almost all cell types makes it an ideal receptor for viral infection. In addition, the negative charge of the highly sulfated HS makes it well suited to interact with viral proteins carrying positive charges (81) .
Evidence also suggests that virus can bind specifically to HS by interacting with specific saccharide sequences (66) . This suggests a relationship between HS structure and viral activity. The structural specificity shown by viral infection could be critical for understanding viral activity. HS serves as a receptor for an array of viruses, including human immunodeficiency virus (HIV), hepatitis-C, human papillomavirus, and Dengue virus (5, 10, 29, 83). In addition, virtually all human herpesviruses, with the possible exception of Epstein Barr virus (EBV), use HS as an initial co-receptor for entry (67) .
Among the herpesviruses, interaction of HS with herpes simplex virus type-1 (HSV-1) has been most studied and therefore, it forms the focus of this review.
HSV-1 belongs to the alphaherpesvirus subfamily of the herpesviruses (67) . It is a neurotropic virus that is highly prevalent among humans. HSV-1 can establish latent infection in the peripheral nervous system, allowing the virus to persist in the host causing life-long infection. HSV-1 infection can result in a number of symptoms ranging from the more common mucocutaneous lesions to more severe, life-threatening symptoms, including meningitis and encephalitis (14). Second, the virus may enter into the cell through endocytosis using a phagocytosis-like uptake mechanism and trigger fusion with the phagosomal membrane (11, 56) . In either case the interaction with HS may be of critical significance. Initially, HS was found to be involved in viral binding during the 
SYNTHESIS OF 3-OS HS
The final modification step during the biosynthesis of HS (summarized in Fig. 1 
USE OF HS AS AN ANTI-HERPETIC AGENT
The most effective and widely used treatment for HSV infection currently is acyclovir (6). However, acyclovir is not always well tolerated and drug- 
